Content about Rare diseases

September 27, 2010

The Food and Drug Administration has approved a generic version of a drug for a...

MUMBAI, India The Food and Drug Administration has approved a generic version of a drug for a devastating muscular disorder.

 

Sun Pharmaceutical Industries announced Tuesday the approval of riluzole hydrochloride in the 50-mg strength. The tablets are used to treat amyotrophic lateral sclerosis or ALS, also known as Lou Gehrig’s disease.

 

 

The drug is a generic version of Sanofi-Aventis’ Rilutek, which has sales of around $50 million, according to Sun.

 

August 29, 2010

BioMarin Pharmaceutical on Monday announced its investigational treatment for a lysosomal storage disorder has received...

August 25, 2010

Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble,...

NEW YORK Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble, according to published reports.

Bloomberg reported Wednesday that Sanofi was unwilling to raise its offer of $70 per share for Genzyme, a Cambridge, Mass.-based company that has carved a niche for itself by manufacturing treatments for such rare genetic disorders as Fabry disease and Pompe disease but lately has been dogged by manufacturing problems.

July 7, 2010

Generic drug maker Hospira will fill and package several drugs for Genzyme, according to published...

May 24, 2010

The Food and Drug Administration has approved a new treatment for a rare genetic disorder...

May 23, 2010

Biotech company Genzyme will pay $175 million to the federal government as part of an...

May 16, 2010

An investigational drug made by Teva Pharmaceutical Industries was not effective in patients with Lou...

March 23, 2010

Genzyme Corp. will have to submit to inspections of one of its plants by the...

February 25, 2010

The Food and Drug Administration has approved a new drug for treating a rare genetic...

February 2, 2010

The Food and Drug Administration has approved a drug for treating a debilitating hand condition...